{
  "meta": {
    "title": "Beta_Oxidation_Of_Fatty_Acids",
    "url": "https://brainandscalpel.vercel.app/beta-oxidation-of-fatty-acids-16051a15.html",
    "scrapedAt": "2025-11-29T18:23:32.348Z"
  },
  "questions": [
    {
      "id": 9151,
      "choices": [
        {
          "id": 36571,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine deficiency</span></span></span></p>"
        },
        {
          "id": 36572,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid synthase deficiency</span></span></span></p>"
        },
        {
          "id": 36573,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tay-Sachs disease</span></span></span></p>"
        },
        {
          "id": 36574,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biotin deficiency</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neurologist is assessing a teenage girl who has been experiencing fatigue severe enough to prevent her participation in physical education classes. She presents with muscle weakness in her limbs. Lab tests indicate high serum levels of triacylglycerols esterified with long-chain fatty acids (LCFAs) and hypoglycemia. A muscle biopsy shows an abundance of lipid vacuoles. What condition do these clinical findings suggest?</span></span></span></p>",
      "unique_key": "Q7254428",
      "question_audio": null,
      "question_video": null,
      "map_id": 30269,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine deficiency</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carnitine deficiency </strong>is seen in <strong>preterm infants</strong>, where <strong>impaired fatty acid oxidation </strong>is noticed &rarr; so <strong>more glucose </strong>is utilized &rarr; episodes of <strong>hypoglycemia</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary carnitine deficiency: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Classical presentation is<strong> hypoketotic hypoglycemic encephalopathy</strong>, <strong>hepatomegaly</strong>, <strong>elevated transaminases and ammonia, cardiomyopathy, pericardial effusion</strong>, <strong>muscle weakness</strong>, <strong>recurrent </strong>episodes of <strong>vomiting </strong>and <strong>diarrhea </strong>and <strong>infections </strong>and <strong>hypochromic anemia</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The above symptoms are <strong>triggered by fasting or viral infections.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Secondary carnitine deficiency</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: c/f<strong>-Hypoketotic hypoglycemia </strong>in <strong>infancy, cardiac and skeletal muscle disease </strong>later in life<strong>, seizures, apnea and developmental delay</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The causes for <strong>secondary carnitine deficiency </strong>includes <strong>organic acidurias, respiratory chain and mitochondrial defects</strong>, <strong>renal Fanconi syndrome </strong>and <strong>drug induced </strong>(<strong>valproic acid, zidovudine</strong>).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affects the <strong>de novo synthesis </strong>of <strong>fatty acids </strong>occurs in the <strong>cytoplasm </strong>with the help of a <strong>dimeric multi-enzyme complex </strong>termed <strong>Fatty acid synthase</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of hexosaminidase A </strong>leads to accumulation of <strong>Ganglioside (GM2). C/F</strong>-<strong>Mental retardation, Cherry red spot in the macula </strong>with Progressive deterioration and <strong>death by 3&ndash;4 years.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Biotin deficiency includes <strong>dermatitis, atrophic glossitis, hyperesthesia, muscle pain, anorexia </strong>and <strong>hallucinations</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical manifestations of <strong>carnitine deficiency</strong>, including <strong>muscle weakness, elevated serum triacylglycerols </strong>with <strong>LCFAs, hypoglycemia</strong>, and <strong>lipid accumulation in muscle cells</strong>, which reflect the <strong>impaired transport </strong>of <strong>fatty acids </strong>into mitochondria for <strong>&beta;-oxidation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:p 224,231.</span></strong></span></span></p>",
      "correct_choice_id": 36571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9174,
      "choices": [
        {
          "id": 36663,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Takes place in mitochondria</span></span></span></p>"
        },
        {
          "id": 36664,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Produce dicarboxylic acids</span></span></span></p>"
        },
        {
          "id": 36665,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADPH and cytochrome P-450 play a role</span></span></span></p>"
        },
        {
          "id": 36666,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Involves methyl group at omega end</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify an incorrect statement about omega-oxidation of fatty acids:</span></span></span></p>",
      "unique_key": "Q3352508",
      "question_audio": null,
      "question_video": null,
      "map_id": 30280,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A)</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Takes place in mitochondria</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a minor pathway taking place in <strong>microsomes (Endoplasmic reticulum), </strong>with the help of <strong>hydroxylase </strong>enzymes such as <strong>NADPH and cytochrome P-450. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>CH3 </strong>group is converted to<strong> CH2OH and oxidized </strong>with the help of <strong>NAD+ to a COOH </strong>group to produce <strong>dicarboxylic acids. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&omega;-oxidation </strong>becomes important when <strong>&beta;-oxidation is defective </strong>and <strong>dicarboxylic acids </strong>(<strong>6C </strong>and <strong>8C </strong>acids) are <strong>excreted </strong>in urine resulting in <strong>dicarboxylic aciduria. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Produce dicarboxylic acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True</strong>, <strong>omega-oxidation </strong>can result in the production of <strong>dicarboxylic acids </strong>when the <strong>omega carbon of fatty acids </strong>is <strong>oxidized</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: NADPH and cytochrome P-450 play a role</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True</strong>, <strong>omega-oxidation </strong>involves the <strong>cytochrome P-450 enzyme </strong>system, which <strong>utilizes NADPH </strong>as a <strong>cofactor</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Involves methyl group at omega end</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True</strong>, <strong>omega-oxidation </strong>involves the <strong>oxidation </strong>of the <strong>methyl group </strong>at the <strong>omega (last carbon) </strong>end of fatty acids.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Omega-oxidation of fatty acids </strong>takes place primarily in the <strong>endoplasmic reticulum </strong>of cells, <strong>not in mitochondria</strong>. This pathway serves as an <strong>alternative to the &beta;-oxidation of fatty acids</strong>, which occurs in <strong>mitochondria and peroxisomes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 205</span></strong></span></span></p>",
      "correct_choice_id": 36663,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9159,
      "choices": [
        {
          "id": 36603,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of phytanic acid</span></span></span></p>"
        },
        {
          "id": 36604,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of dicarboxylic acid</span></span></span></p>"
        },
        {
          "id": 36605,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of propionyl CoA</span></span></span></p>"
        },
        {
          "id": 36606,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of acetyl CoA</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents to the clinic with progressive difficulty in night vision and a recent history of unsteady gait. He reports no significant medical history except for a strict vegetarian diet for many years. Physical examination reveals mild hepatomegaly and decreased ankle reflexes. Laboratory tests show elevated plasma levels of a specific fatty acid. The patient&rsquo;s condition is suspected to be due to a metabolic disorder affecting fatty acid catabolism:</span></span></span></p>",
      "unique_key": "Q7459435",
      "question_audio": null,
      "question_video": null,
      "map_id": 30273,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A)</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Accumulation of phytanic acid </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha oxidation </strong>is removal of <strong>1C </strong>at a time from <strong>COOH end&nbsp; </strong>and its takes place in <strong>peroxisomes</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eg: <strong>Phytanic acid </strong>(require prior <strong>&alpha;-oxidation to proceed to &szlig;-oxidation</strong>).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So, <strong>defective or lack of alpha oxidation </strong>of <strong>phytanic acid </strong>leads to <strong>its accumulation. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Formation of dicarboxylic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Dicarboxylic acids accumulate as a result of <strong>&omega;-oxidation, </strong>which typically occurs when <strong>&beta;-oxidation is impaired, not </strong>&alpha;-oxidation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Formation of propionyl CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Propionyl CoA is a product of the<strong> &beta;-oxidation </strong>of <strong>odd-chain fatty acids</strong>, <strong>not </strong>related to <strong>&alpha;-oxidation defects</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Formation of acetyl CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Acetyl CoA </strong>is a product of <strong>&beta;-oxidation of fatty acids</strong>. <strong>Lack </strong>of <strong>&alpha;-oxidation </strong>does <strong>not </strong>directly lead to the formation of <strong>acetyl CoA.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lack </strong>of <strong>&alpha;-oxidation of fatty acids </strong>leads to the accumulation of <strong>phytanic acid</strong>, a <strong>branched-chain fatty acid </strong>derived mainly from <strong>dietary sources</strong>, particularly <strong>ruminant fats</strong>. Humans <strong>lack </strong>the enzymes to introduce a <strong>double bond </strong>in <strong>phytanic acid</strong>, making <strong>&alpha;-oxidation </strong>necessary for <strong>its catabolism</strong>. <strong>Deficiencies </strong>in this pathway, such as in <strong>Refsum disease</strong>, lead to the accumulation of <strong>phytanic acid</strong>, which is <strong>toxic </strong>to cells and can cause symptoms like <strong>night blindness, ataxia, and peripheral neuropathy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed ,pg 231</span></strong></span></span></p>",
      "correct_choice_id": 36603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9147,
      "choices": [
        {
          "id": 36555,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H2O2 </span></span></span></p>"
        },
        {
          "id": 36556,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA</span></span></span></p>"
        },
        {
          "id": 36557,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Different enzymes are found in different site</span></span></span></p>"
        },
        {
          "id": 36558,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADH is required</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is this difference in the production of byproducts between beta-oxidation in peroxisomes and that in mitochondria?</span></span></span></p>",
      "unique_key": "Q6533901",
      "question_audio": null,
      "question_video": null,
      "map_id": 30267,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H2O2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Beta-oxidation </strong>in <strong>peroxisomes </strong>differs from <strong>mitochondrial beta-oxidation </strong>in that it produces <strong>hydrogen peroxide (H2O2) </strong>as a <strong>byproduct</strong>. <strong>Peroxisomal oxidation </strong>involves enzymes that transfer <strong>electrons directly to oxygen</strong>, forming <strong>H2O2</strong>. This <strong>byproduct </strong>is then <strong>broken </strong>down by <strong>catalase</strong>, which is <strong>abundant </strong>in <strong>peroxisomes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Acetyl CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Both peroxisomal and mitochondrial beta-oxidation </strong>generate <strong>acetyl CoA</strong>, so this is <strong>not </strong>a distinguishing feature.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Different enzymes are found in different sites</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While it&#39;s <strong>true that different enzymes catalyze </strong>the steps of <strong>beta-oxidation in peroxisomes and mitochondria</strong>, this option does <strong>not </strong>refer to a <strong>unique byproduct </strong>of the <strong>reaction</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: NADH is required</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: NADH is a product of <strong>mitochondrial beta-oxidation </strong>where it is later <strong>used in the electron transport chain </strong>to generate <strong>ATP</strong>. <strong>Peroxisomal oxidation </strong>does <strong>not </strong>contribute directly to the <strong>electron </strong>transport chain and therefore the role of <strong>NADH </strong>in <strong>peroxisomal beta-oxidation </strong>is <strong>not </strong>a key distinguishing feature in the context of byproduct production.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>modified beta-oxidation pathway </strong>takes place in <strong>peroxisomes for fatty Acids </strong>&gt; <strong>C20, C22 (VLCFs)</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxidation </strong>in the <strong>Peroxisomes </strong>&rarr; produces <strong>Acetyl CoA and H2O2 </strong>(instead of FADH2)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>No ATP </strong>is generated.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Further oxidation </strong>of<strong> Acetyl CoA and Octanoyl CoA </strong>takes place in the <strong>mitochondria</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e page 226</span></strong></span></span></p>",
      "correct_choice_id": 36555,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9101,
      "choices": [
        {
          "id": 36371,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Short chain fatty acids</span></span></span></p>"
        },
        {
          "id": 36372,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long chain fatty acids</span></span></span></p>"
        },
        {
          "id": 36373,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medium chain fatty acids</span></span></span></p>"
        },
        {
          "id": 36374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Very long chain fatty acids</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a pediatric clinic, a physician evaluates a 7-month-old male infant presented by his mother with concerns about hypotonia, hepatomegaly, and delayed developmental milestones. Suspecting Zellweger syndrome, a peroxisomal disorder, the physician considers the metabolic abnormalities associated with this condition. Which type of fatty acids is known to accumulate in patients with Zellweger syndrome?</span></span></span></p>",
      "unique_key": "Q7342559",
      "question_audio": null,
      "question_video": null,
      "map_id": 30265,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Very long chain fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>&nbsp;&nbsp;&nbsp;</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is also known as <strong>Cerebrohepatorenal syndrome</strong> which is due to <strong>defective oxidation</strong> of <strong>very long</strong> <strong>chain fatty acids (VLCFA).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>mutations </strong>in <strong>peroxins genes</strong> , <strong>entry</strong> of enzymes into the <strong>peroxisomes </strong>are denied causing<strong> insufficient oxidation</strong> of <strong>VLCFA</strong> leading to <strong>its accumulation in CNS</strong> causing <strong>neurological impairment and death in childhood.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It usually<strong> presents at birth </strong>with profound <strong>neurologic impairment </strong>and the <strong>victims</strong> often <strong>dying within a year.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> They <strong>do not</strong> require <strong>carnitine</strong> for transport across the<strong> inner mitochondrial membrane</strong> and so are <strong>easily oxidized.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Long chain fatty acid</strong> accumulation is due to deficiency of <strong>long chain acyl CoA dehydrogenase </strong>resulting in <strong>Nonketotic</strong> <strong>hypoglycaemia</strong> with<strong> low carnitine</strong> and<strong> increased acyl carnitine </strong>in plasma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>MCAD</strong> accumulation occurs due to <strong>deficiency of medium chain acyl CoA dehydrogenase </strong>results in <strong>acidosis,</strong> <strong>hyperammonemia, hypoglycaemia</strong> and<strong> fatty liver.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome</strong> is a<strong> peroxisomal</strong> disorder characterized by the <strong>absence or malfunction of peroxisomes</strong> in the cells. One of the key functions of<strong> peroxisomes is the &beta;-oxidation of very long chain fatty acids (VLCFAs).</strong><strong> </strong>In <strong>Zellweger syndrome</strong>, the<strong> inability to</strong> <strong>metabolize VLCFAs</strong> leads to their<strong> accumulation in tissues and blood,</strong> contributing to the<strong> clinical manifestations of the disorder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 241,614</span></strong></span></span></p>",
      "correct_choice_id": 36374,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9157,
      "choices": [
        {
          "id": 36595,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jamaican Vomiting Sickness</span></span></span></p>"
        },
        {
          "id": 36596,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome</span></span></span></p>"
        },
        {
          "id": 36597,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine deficiency</span></span></span></p>"
        },
        {
          "id": 36598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propionyl CoA carboxylase deficiency</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old man from Africa with a history of diabetes presents with severe vomiting, epigastric pain, and confusion. He has been using local herbal remedies to manage his blood sugar for the last 8 months and is concerned about possible overconsumption. On examination, he is comatose, dehydrated, and shows signs of tachycardia and tachypnea. Laboratory tests reveal hypoglycemia at 53 mg/dl and a significant electrolyte imbalance. His urine is positive for a high amount of dicarboxylic acid? </span></span></span></p>",
      "unique_key": "Q5826771",
      "question_audio": null,
      "question_video": null,
      "map_id": 30272,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jamaican Vomiting Sickness</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ackee fruit </strong>that grows in<strong> Jamaica and West Africa </strong>contain a<strong> toxin</strong> called <strong>Hypoglycin,</strong> which is an <strong>inhibitor of fatty acyl</strong> <strong>CoA dehydrogenase.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It causes <strong>severe Hypoglycemia</strong> if <strong>ingested</strong> as it<strong> inhibits beta oxidation of fatty acids.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by <strong>sudden </strong>onset of <strong>vomiting 2&ndash;6 hrs after ingestion</strong>, followed by <strong>convulsion, coma and death.&nbsp; </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Defective</strong> oxidation of<strong> VLCFA</strong> &rarr; accumulation of <strong>VLCFA in CNS </strong>&rarr; causes <strong>neurological impairment and death </strong>in childhood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option C:&nbsp; Carnitine deficiency&nbsp;I&nbsp;&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is reported in <strong>preterm infants </strong>with <strong>impaired fatty acid oxidation </strong>&rarr; <strong>more glucose </strong>is utilized &rarr; <strong>hypoglycemia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Characterized by <strong>propionic acidemia, ketoacidosis</strong>, and <strong>mental abnormalities.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Jamaican Vomiting Sickness</strong>, which is <strong>caused </strong>by the ingestion of <strong>unripe ackee fruit </strong>containing <strong>hypoglycin A</strong>, a<strong> toxin </strong>that<strong> inhibits </strong>fatty acid oxidation. The resulting <strong>buildup </strong>of <strong>dicarboxylic acids </strong>in the <strong>urine </strong>and <strong>hypoglycemia </strong>due to <strong>impaired gluconeogenesis </strong>are indicative of this <strong>diagnosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 219</span></strong></span></span></p>",
      "correct_choice_id": 36595,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8957,
      "choices": [
        {
          "id": 35795,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propionic acidemia </span></span></span></p>"
        },
        {
          "id": 35796,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LCACDH deficiency </span></span></span></p>"
        },
        {
          "id": 35797,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutaric aciduria</span></span></span></p>"
        },
        {
          "id": 35798,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCAD deficiency</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-day-old male infant, previously healthy, is brought to the emergency department by his mother due to sudden onset of dyspnea followed by loss of consciousness. The infant was born via normal vaginal delivery and had been well until this episode. Tragically, within an hour of arrival, the infant passed away.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/3_9N1ABtU.jpg\" style=\"height:205px; width:291px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laboratory investigations revealed the following critical findings:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood sugar: 25 mg/dL, indicating profound hypoglycemia.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated levels of medium-chain acylcarnitines.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Significant presence of dicarboxylic acids in the urine.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the clinical presentation and laboratory findings, which of the following is the most probable diagnosis?</span></span></span></p>",
      "unique_key": "Q4721738",
      "question_audio": null,
      "question_video": null,
      "map_id": 30283,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MCAD Deficiency </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MCAD deficiency </strong>is a disorder of <strong>fatty acid oxidation</strong> that <strong>prevents the body </strong>from<strong> converting certain fats into energy</strong>, particularly <strong>during fasting</strong>. This can lead to episodes of <strong>low blood sugar (hypoglycemia), weakness, and lethargy</strong>. The critical findings in this case&mdash;<strong>profound hypoglycemia,</strong> <strong>elevated</strong> levels of <strong>medium-chain acylcarnitines</strong>, and the <strong>presence of dicarboxylic acids</strong> in the <strong>urine</strong>&mdash;are hallmark indicators of <strong>MCAD deficiency. </strong>These s<strong>ubstances accumulate</strong> due to the <strong>inability </strong>to break down <strong>medium-chain fatty acids</strong>, leading to the <strong>clinical presentation observed</strong> in this<strong> infant.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propionic Acidemia -&nbsp;</strong>Characterized by the <strong>accumulation of propionic acid, </strong>this condition typically presents with a <strong>metabolic acidosis </strong>rather than the specific <strong>metabolic derangements</strong> seen in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: LCACDH Deficiency -&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition affects the<strong> metabolism of long-chain fatty acids. </strong>The <strong>laboratory findings </strong>in this <strong>infant,</strong> however, are<strong> indicative of a disorder </strong>involving<strong> medium-chain fatty acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glutaric Aciduria -&nbsp;</strong>This <strong>metabolic disorder</strong> leads to the accumulation of <strong>glutaric acid </strong>and typically presents with <strong>macrocephaly and neurological signs,</strong> which were<strong> not </strong>reported in this case.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MCAD deficiency</strong> - Key diagnostic markers include <strong>hypoglycemia, elevated medium-chain acylcarnitines, and dicarboxylic aciduria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 204.</span></strong></span></span></p>",
      "correct_choice_id": 35798,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9171,
      "choices": [
        {
          "id": 36651,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the correct explanation of A</span></span></span></p>"
        },
        {
          "id": 36652,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
        },
        {
          "id": 36653,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A</span></span></span></p>"
        },
        {
          "id": 36654,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hypoglycaemia is common in preterm neonates.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R):</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Carnitine deficiency is seen in preterm infants, who have impaired fatty acid oxidation causing more glucose utilization.</span></span></span></p>",
      "unique_key": "Q2278776",
      "question_audio": null,
      "question_video": null,
      "map_id": 30279,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) A as well as R are right and R is a correct explanation of A</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypoglycemia </strong>is indeed common in <strong>preterm neonates </strong>(Assertion A), partly because of their <strong>immature hepatic glycogen stores </strong>and the <strong>higher brain-to-body </strong>mass ratio leading to a <strong>rapid glucose consumption</strong>.<strong> Carnitine deficiency </strong>(Reasoning R) is also more frequent in <strong>preterm infants </strong>due to <strong>inadequate stores </strong>and <strong>less maternal transfer</strong>, which leads to <strong>impaired fatty acid oxidation</strong>, a process that <strong>normally </strong>helps to <strong>conserve glucose</strong>. Thus, with <strong>compromised fatty acid oxidation, more glucose is utilized</strong>, contributing to the risk of<strong> hypoglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carnitine deficiency </strong>is noted in <strong>preterm infants</strong>, in whom <strong>impaired fatty acid oxidation </strong>are seen. So <strong>more glucose </strong>is utilized, resulting in <strong>recurrent episodes of hypoglycaemia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 202</span></strong></span></span></p>",
      "correct_choice_id": 36653,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9144,
      "choices": [
        {
          "id": 36543,
          "text": "<p><span style=\"font-size:12.0pt;\">Carnitine palmitoyl transferase I</span></p>"
        },
        {
          "id": 36544,
          "text": "<p><span style=\"font-size:12.0pt;\">Acyl Co- dehydrogenase</span></p>"
        },
        {
          "id": 36545,
          "text": "<p><span style=\"font-size:12.0pt;\">Carnitine palmitoyl transferase II</span></p>"
        },
        {
          "id": 36546,
          "text": "<p><span style=\"font-size:12.0pt;\">Carnitine acylcarnitine translocase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Based on the diagram provided, which enzyme is not involved in shuttling fatty acids into the mitochondrial matrix for -oxidation?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(1).png\" width=\"1080\" height=\"634\"></p>",
      "unique_key": "Q8317698",
      "question_audio": null,
      "question_video": null,
      "map_id": 30266,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: B. Acyl Co-A dehydrogenase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagram shows the carnitine shuttle system, which is responsible for transporting long-chain fatty acids from the cytosol into the mitochondrial matrix, where -oxidation occurs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acyl Co-A Dehydrogenase</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Location: Mitochondrial matrix</span></li><li><span style=\"font-size:12.0pt;\">Function: Catalyzes the first step of -oxidation, dehydrogenating Acyl-CoA to form a trans double bond between the  and  carbons.</span></li><li><span style=\"font-size:12.0pt;\">Involved in shuttle?&nbsp; No  it acts after the fatty acid has already entered the matrix.</span></li></ul><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Carnitine Palmitoyl Transferase I (CPT I)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Location: Outer mitochondrial membrane</span></li><li><span style=\"font-size:12.0pt;\">Function: Converts Acyl-CoA to Acyl-carnitine by transferring the fatty acid to carnitine.</span></li><li><span style=\"font-size:12.0pt;\">Involved in shuttle? Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carnitine Palmitoyl Transferase II (CPT II)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Location: Inner mitochondrial membrane (matrix side)</span></li><li><span style=\"font-size:12.0pt;\">Function: Converts Acyl-carnitine back to Acyl-CoA and carnitine, allowing the fatty acid to enter -oxidation.</span></li><li><span style=\"font-size:12.0pt;\">Involved in shuttle? Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Carnitine Acylcarnitine Translocase</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Location: Inner mitochondrial membrane</span></li><li><span style=\"font-size:12.0pt;\">Function: Transports Acyl-carnitine into the mitochondrial matrix while moving free carnitine back to the cytosol in a counter-transport manner.</span></li><li><span style=\"font-size:12.0pt;\">Involved in shuttle? Yes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Your%20paragraph%20text%20(2)_2MKFtfT.png\" width=\"1080\" height=\"1080\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Role of carnitine in the transport of long-chain fatty acids through the inner mitochondrial membrane.</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Long-chain acyl-CoA formed by acyl-CoA synthetase enters the intermembrane space. For transport across the inner membrane, acyl groups must be transferred from CoA to carnitine by carnitine palmitoyl transferase-I. The acylcarnitine formed is then carried into the matrix by a translocase enzyme in exchange for a free carnitine and acyl-CoA is reformed by carnitine palmitoyltransferase-II.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand the carnitine shuttle system, which is essential for the mitochondrial import of long-chain fatty acids. Key enzymes involved include CPT I, CPT II, and the translocase. Acyl-CoA dehydrogenase is not involved in transportit functions after the fatty acid enters the matrix, initiating -oxidation.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9/ ed: p151, Harper 30/e: p 224</span></p>",
      "correct_choice_id": 36544,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9155,
      "choices": [
        {
          "id": 36587,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infantile Refsum&rsquo;s disease</span></span></span></p>"
        },
        {
          "id": 36588,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome</span></span></span></p>"
        },
        {
          "id": 36589,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine deficiency</span></span></span></p>"
        },
        {
          "id": 36590,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propionyl CoA carboxylase deficiency</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old girl child brought by her parents with complaints of difficulty in swallowing food, impaired vision at night and hearing impairment for the past 5 months seems to be worsening. O/E: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/4.jpg\" style=\"height:276px; width:173px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EYES: Bilateral nystagmus</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FEET: 4th phalange was short in both feet</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SKIN: dry</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electroretinogram: Retinal pigmentation in both fundi.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lab reports: elevated VLCFA and phytanic acid.&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most probable diagnosis?</span></span></span></p>",
      "unique_key": "Q4251544",
      "question_audio": null,
      "question_video": null,
      "map_id": 30271,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infantile Refsum&rsquo;s disease</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The constellation of symptoms such as <strong>difficulty swallowing, vision and hearing impairment, specific skeletal abnormalities, dry skin, and distinctive retinal pigmentation</strong>, coupled with lab findings of <strong>elevated VLCFAs and phytanic acid</strong>, points to <strong>Infantile Refsum&rsquo;s disease. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>peroxisomal disorder </strong>characterized by <strong>impaired peroxisomal biogenesis </strong>and function, leading to the <strong>accumulation </strong>of <strong>phytanic acid and VLCFAs. </strong>The clinical manifestations are <strong>less severe and present later </strong>than in <strong>Zellweger syndrome</strong>, and the disease typically allows for a <strong>longer lifespan.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Zellweger syndrome:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Defective </strong>oxidation of <strong>VLCFA </strong>&rarr;<strong> accumulation </strong>of VLCFA in <strong>CNS </strong>&rarr; causes<strong> neurological impairment and death </strong>in childhood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Carnitine deficiency&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is reported in <strong>preterm infants with impaired fatty acid oxidation </strong>&rarr; <strong>more glucose </strong>is utilized &rarr; <strong>hypoglycemia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Propionyl CoA carboxylase deficiency:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">characterized by <strong>propionic acidemia, ketoacidosis, and mental abnormalities.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Difficulty swallowing, night blindness, hearing loss, bilateral nystagmus, brachydactyly, dry skin, retinal pigmentation, and elevated VLCFAs </strong>and <strong>phytanic acid </strong>is diagnosed with <strong>Infantile Refsum&rsquo;s disease, </strong>a<strong> peroxisomal disorder.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 205</span></strong></span></span></p>",
      "correct_choice_id": 36587,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9164,
      "choices": [
        {
          "id": 36623,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl-CoA dehydrogenase</span></span></span></p>"
        },
        {
          "id": 36624,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl-CoA synthetase</span></span></span></p>"
        },
        {
          "id": 36625,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/22/screenshot-2024-04-22-153833.png\" style=\"height:12px; width:9px\" />&nbsp;<span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">2-Enoyl-CoA hydratase</span></span></span>&nbsp;</p>"
        },
        {
          "id": 36626,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">L (+)-3-Hydroxyacyl-CoA dehydrogenase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old male long-distance runner presents to his primary care physician with complaints of muscle cramps and fatigue during exercise. He follows a strict low-carbohydrate, high-fat diet and is concerned about his energy levels. Intrigued by the metabolic processes that provide energy during prolonged exercise, he asks about the step in fatty acid oxidation that requires an input of energy. The physician, recognizing this as an important aspect of fatty acid metabolism that could impact the patient&rsquo;s symptoms, decides to review the biochemical pathway:</span></span></span></p>",
      "unique_key": "Q5182004",
      "question_audio": null,
      "question_video": null,
      "map_id": 30276,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl-CoA synthetase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>first step of fatty acid oxidation</strong> requires activation of the <strong>fatty acid to an acyl-CoA. </strong>This reaction is catalyzed by the <strong>enzyme acyl-CoA synthetase</strong> and requires <strong>ATP </strong>which hydrolyses to <strong>AMP ~ two high energy phosphates.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/6.jpg\" style=\"height:191px; width:602px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In subsequent reactions,<strong> two carbons </strong>are removed at a time from the <strong>carboxyl end </strong>to form <strong>acetyl-CoA</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>fatty acyl CoA </strong>is <strong>dehydrogenated </strong>to a<strong> transenoyl CoA </strong>by the <strong>enzyme Acyl-CoA dehydrogenase </strong>with <strong>FAD </strong>accepting the hydrogen atoms.&nbsp; <strong>FADH2 </strong>when oxidised in <strong>electron transport chain </strong>will produce <strong>1.5 ATP </strong>molecules</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Enoyl CoA hydratase</strong> catalyzes the step which forms a <strong>beta-hydroxy fatty acyl CoA.</strong> The <strong>L isomer</strong> alone is formed during the <strong>hydration</strong> of the <strong>trans-double bond.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>beta-hydroxy fatty acyl CoA</strong> is again<strong> oxidized</strong> to form <strong>beta-keto fatty acyl CoA </strong>producing a<strong> NADH</strong>. which <strong>further </strong>gets<strong> </strong>oxidized in <strong>electron transport chain</strong> generating <strong>2.5 ATPs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acyl-CoA synthetase</strong> is the enzyme responsible for <strong>catalyzing </strong>the initial step in<strong> fatty acid oxidation </strong>where a<strong> fatty acid</strong> is activated to form <strong>acyl-CoA</strong>. This reaction requires the <strong>hydrolysis of ATP to AMP </strong>and <strong>pyrophosphate (PPi)</strong>, making it the <strong>only step in fatty acid</strong> <strong>oxidation</strong> that requires an <strong>input of energy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: DM Vasudevan 9/e: p 203</span></strong></span></span></p>",
      "correct_choice_id": 36624,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9166,
      "choices": [
        {
          "id": 36631,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl carrier protein</span></span></span></p>"
        },
        {
          "id": 36632,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine</span></span></span></p>"
        },
        {
          "id": 36633,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LCAT</span></span></span></p>"
        },
        {
          "id": 36634,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CETP</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a history of congestive heart failure is undergoing a cardiac rehabilitation program. His cardiologist explains the importance of fatty acid metabolism in cardiac muscle for energy production. She details how fatty acids are transported into the mitochondria for &beta;-oxidation, a process especially vital in cardiac tissue, which primarily uses fatty acid oxidation to meet its energy needs. Given the heart&#39;s reliance on fatty acids for energy, the cardiologist emphasizes one particular molecule&#39;s role in transporting fatty acids across the inner mitochondrial membrane:</span></span></span></p>",
      "unique_key": "Q6822254",
      "question_audio": null,
      "question_video": null,
      "map_id": 30277,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carnitine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acids</strong> are activated in the <strong>cytoplasm</strong>; but <strong>beta-oxidation </strong>takes place in <strong>mitochondria. </strong>So,<strong> transport of fatty acids</strong> across the<strong> mitochondrial membrane</strong> is essential. </span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> LCFA CoA cannot </strong>pass through the<strong> inner mitochondrial membrane </strong>and requires a <strong>transporter, carnitine</strong> for transfer of<strong> fatty acids (see fig.).</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/7.jpg\" style=\"height:625px; width:602px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Acyl carrier protein:&nbsp; </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Forms a part of <strong>fatty acid synthase complex</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&copy; LCAT:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Lecithin-cholesterol acyl transferase. </strong>Involved in <strong>HDL metabolism</strong>.<strong> Apo Al of HDL</strong> activates<strong> LCAT.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp; D: CETP:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> cholesterol ester</strong> from <strong>HDL </strong>is transferred to <strong>VLDL, IDL and LDL</strong> by a <strong>Cholesterol Ester Transfer Protein.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carnitine</strong> is crucial for the transport of<strong> long-chain fatty acids</strong> across the <strong>inner mitochondrial membrane </strong>in <strong>cardiac muscle.</strong> It forms a <strong>complex with fatty acids </strong>to facilitate their <strong>translocation into the mitochondria,</strong> where <strong>&beta;-oxidation</strong> occurs to generate <strong>ATP for energy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 202</span></strong></span></span></p>",
      "correct_choice_id": 36632,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9184,
      "choices": [
        {
          "id": 36703,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased hydrolysis of fat from adipocytes</span></span></span></p>"
        },
        {
          "id": 36704,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased synthesis of fatty acids</span></span></span></p>"
        },
        {
          "id": 36705,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased [NADH]/[NAD+) ratio</span></span></span></p>"
        },
        {
          "id": 36706,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impaired beta oxidation of fatty acids</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old man with a history of chronic alcohol abuse presents to the emergency department with severe abdominal pain. An ultrasound of the abdomen reveals fatty liver. The emergency medicine physician begins to explain to the medical students present that chronic alcohol consumption can lead to hepatic steatosis and outlines the pathophysiological mechanisms behind this condition:</span></span></p>",
      "unique_key": "Q7800091",
      "question_audio": null,
      "question_video": null,
      "map_id": 30282,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impaired beta oxidation of fatty acids. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>alcoholic liver disease</strong>, the metabolism of <strong>alcohol</strong> significantly <strong>increases the NADH/NAD+ ratio</strong> in <strong>hepatocytes</strong>, which in turn <strong>impairs </strong>the <strong>beta oxidation of fatty acids.</strong> This occurs because the <strong>excess NADH inhibits</strong> the<strong> citric acid cycle</strong>, leading to an accumulation of <strong>acetyl-CoA and fatty acids</strong> within the <strong>liver</strong>. This <strong>impaired fatty acid oxidation</strong>, along with <strong>increased lipogenesis </strong>and <strong>decreased VLDL secretion</strong>, contributes to the development of <strong>fatty liver, or hepatic steatosis, </strong>in <strong>chronic alcoholics.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Increased hydrolysis of fat from adipocytes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While alcohol can <strong>increase lipolysis</strong>, the key issue in <strong>alcoholic fatty liver disease </strong>is the <strong>impairment </strong>of <strong>fatty acid oxidation</strong>, rather than an increase in the hydrolysis of fat from adipocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Decreased synthesis of fatty acids</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Alcohol consumption </strong>typically leads to an <strong>increase</strong>, <strong>not </strong>a <strong>decrease</strong>, in the <strong>synthesis </strong>of <strong>fatty acids </strong>in the<strong> liver</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Decreased [NADH]/[NAD+] ratio</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Alcohol metabolism </strong>actually <strong>increases </strong>the <strong>[NADH]/[NAD+] ratio</strong>, which is <strong>one factor </strong>contributing to <strong>impaired fatty acid oxidation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increased </strong>level of <strong>acetyl CoA </strong>causes <strong>increased fatty acid synthesis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Impaired beta oxidation of fatty acids </strong>leads to <strong>increased TAG </strong>in the <strong>liver </strong>resulting in <strong>fatty liver and steatosis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: p317.</span></strong></span></span></p>",
      "correct_choice_id": 36706,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9149,
      "choices": [
        {
          "id": 36563,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased ability to convert acetyl coenzyme A to glucose</span></span></span></p>"
        },
        {
          "id": 36564,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased acetyl CoA production</span></span></span></p>"
        },
        {
          "id": 36565,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased conversion of acetyl coenzyme A to acetoacetate</span></span></span></p>"
        },
        {
          "id": 36566,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased production of ATP and nicotinamide adenine dinucleotide</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatrician is evaluating a 7-month-old boy who was admitted with a seizure, gastrointestinal symptoms, and decreased appetite. Laboratory tests show severe hypoglycemia, normal blood carnitine levels, absence of ketones in the urine, and the presence of various dicarboxylic acids. These findings suggest a diagnosis of medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency. Considering the biochemistry of MCAD deficiency, what is the underlying cause of fasting hypoglycemia in this condition?</span></span></span></p>",
      "unique_key": "Q7744626",
      "question_audio": null,
      "question_video": null,
      "map_id": 30268,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased acetyl CoA production</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MCAD deficiency </strong>impairs the body&#39;s ability to <strong>break down medium-chain fatty acids </strong>due to a <strong>lack of functional MCAD enzyme</strong>. This <strong>impedes </strong>the production of <strong>acetyl CoA </strong>from these <strong>fatty acids </strong>during <strong>fasting</strong>, when the <strong>body normally </strong>relies on <strong>fat oxidation </strong>for <strong>energy</strong>. <strong>Acetyl CoA </strong>is crucial for maintaining <strong>blood glucose levels via gluconeogenesis </strong>during periods <strong>without food</strong>. In <strong>MCAD deficiency</strong>, the <strong>reduced </strong>availability of <strong>acetyl CoA limits gluconeogenesis, </strong>leading to <strong>fasting hypoglycemia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Other Options:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Decreased ability to convert acetyl coenzyme A to glucose</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Acetyl CoA cannot </strong>be converted to <strong>glucose in humans </strong>due to the <strong>irreversibility </strong>of the <strong>pyruvate dehydrogenase </strong>reaction, which is <strong>not </strong>specific to <strong>MCAD </strong>deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Increased conversion of acetyl coenzyme A to acetoacetate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>MCAD deficiency </strong>would actually lead to a <strong>decreased production of ketone bodies </strong>like <strong>acetoacetate </strong>because there is <strong>less acetyl CoA </strong>available from <strong>fatty acid oxidation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Increased production of ATP and NAD</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>MCAD deficiency </strong>would result in <strong>decreased </strong>production of <strong>ATP </strong>and <strong>NADH </strong>from <strong>medium-chain fatty acid oxidation </strong>because the <strong>fatty acids </strong>are <strong>not </strong>being properly <strong>metabolized</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MCAD deficiency </strong>leads to <strong>decreased acetyl CoA </strong>production from <strong>medium-chain fatty acids</strong>, which <strong>impairs gluconeogenesis </strong>and <strong>energy </strong>production during <strong>fasting</strong>, resulting in <strong>hypoglycemia</strong>. The <strong>disease </strong>also leads to an <strong>accumulation of fatty acid</strong> metabolites, such as <strong>dicarboxylic acids</strong>, in the <strong>blood and urine</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p204.</span></strong></span></span></p>",
      "correct_choice_id": 36564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9153,
      "choices": [
        {
          "id": 36579,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome</span></span></span></p>"
        },
        {
          "id": 36580,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infantile Refsum&rsquo;s Disease</span></span></span></p>"
        },
        {
          "id": 36581,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Refsum&rsquo;s Disease</span></span></span></p>"
        },
        {
          "id": 36582,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Organic Acidurias</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A neonate in the NICU presents with seizures, poor muscle tone, feeding difficulties, distinct facial features, bilateral cataracts, and ultrasound findings of renal cysts. Blood work indicates elevated very long-chain fatty acids (VLCFAs), reduced levels of plasmalogen, and increased levels of cholestenoic acid. Based on these clinical findings, what is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/3.jpg\" style=\"height:216px; width:218px\" /></span></span></span></span></p>",
      "unique_key": "Q1981460",
      "question_audio": null,
      "question_video": null,
      "map_id": 30270,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zellweger syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome </strong>is due to <strong>defective oxidation of very long chain fatty acids (VLCFA). </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Peroxisomes </strong>are <strong>empty or peroxisomal enzymes </strong>are <strong>not </strong>transported correctly into <strong>peroxisomes </strong>&rarr; leads to <strong>insufficient </strong>oxidation of <strong>VLCFA </strong>&rarr;<strong> accumulation </strong>of <strong>VLCFA </strong>in <strong>CNS </strong>&rarr; <strong>neurological impairment and death </strong>in childhood.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome, adrenoleukodystrophy and infantile Refsum&rsquo;s disease </strong>are together classified as <strong>Peroxisomal biogenesis disorders</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Infantile Refsum&#39;s Disease:&nbsp; </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is also a <strong>peroxisomal disorder </strong>&rarr; <strong>phytanic acid</strong> accumulation along with <strong>VLCFA </strong>&amp; <strong>Children do not survive long.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp; C. Refsum&#39;s Disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to <strong>lack of alpha-hydroxylase </strong>&rarr; <strong>alpha oxidation </strong>does <strong>not </strong>occur &rarr; <strong>phytanic acid </strong>accumulates in the tissues &rarr; <strong>C/F: severe neurological symptoms</strong>, <strong>polyneuropathy</strong>, <strong>retinitis pigmentosa</strong>, <strong>nerve deafness and cerebellar ataxia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Organic Acidurias:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Disorders </strong>of metabolism of <strong>fatty acids, branched&nbsp;</strong></span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chain, aromatic amino acids and citric acid cycle </strong>&rarr; accumulation of <strong>organic acids </strong>in body tissues and their <strong>excretion in urine </strong>&rarr; <strong>acidosis, vomiting, convulsions and coma</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome</strong>, a <strong>peroxisomal biogenesis disorder</strong>, is characterized by the <strong>absence </strong>of functional <strong>peroxisomes</strong>, which leads to the <strong>accumulation of VLCFAs </strong>and <strong>defects </strong>in <strong>plasmalogen </strong>synthesis necessary for <strong>normal cell membrane function</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation, including distinctive <strong>facial features, cataracts, and renal cysts</strong>, along with the <strong>specific biochemical abnormalities</strong>, strongly suggests <strong>Zellweger syndrome.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p209, 254</span></strong></span></span></p>",
      "correct_choice_id": 36579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9161,
      "choices": [
        {
          "id": 36611,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">106 ATP</span></span></span></p>"
        },
        {
          "id": 36612,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">142 ATP</span></span></span></p>"
        },
        {
          "id": 36613,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">129 ATP</span></span></span></p>"
        },
        {
          "id": 36614,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">139 ATP</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old biochemistry researcher is analyzing energy yield from various metabolic pathways. He is particularly interested in the total ATP production from the complete oxidation of palmitic acid, a common saturated fatty acid. In his experimental setup, he meticulously accounts for all the steps involved in &beta;-oxidation, the citric acid cycle, and the electron transport chain, ensuring accurate calculations of ATP yield:</span></span></span></p>",
      "unique_key": "Q6626828",
      "question_audio": null,
      "question_video": null,
      "map_id": 30274,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">106 ATP&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxidation </strong>of <strong>C16</strong> fatty acid palmitate: A total of <strong>8 molecules of acetyl-CoA </strong>is formed.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Each gives rise to <strong>10 molecules of ATP </strong>on oxidation in <strong>TCA cycle</strong>, making <strong>80 </strong>molecules. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two </strong>must be <strong>subtracted </strong>for the <strong>initial activation </strong>of the <strong>fatty acid</strong>, yielding a net gain of <strong>106 mol of ATP </strong>per mole of <strong>palmitate.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/5.jpg\" style=\"height:371px; width:602px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>total ATP </strong>yield in <strong>palmitic acid</strong> oxidation is <strong>106 ATP</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/ed ,pg 225</span></strong></span></span></p>",
      "correct_choice_id": 36611,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9162,
      "choices": [
        {
          "id": 36615,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitochondria</span></span></span></p>"
        },
        {
          "id": 36616,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysosomes</span></span></span></p>"
        },
        {
          "id": 36617,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peroxisomes</span></span></span></p>"
        },
        {
          "id": 36618,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nucleus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-month-old infant presents to the pediatrician with hypotonia, hepatomegaly, and developmental delays. The mother reports that the baby has had difficulty feeding and exhibits poor responsiveness to stimuli. Physical examination notes a high forehead, hypertelorism, and epicanthic folds. The physician, suspecting a genetic disorder affecting cellular organelles, orders a series of diagnostic tests, including metabolic screening and imaging:</span></span></span></p>",
      "unique_key": "Q3506656",
      "question_audio": null,
      "question_video": null,
      "map_id": 30275,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Peroxisomes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here the <strong>peroxisomes </strong>are <strong>empty or peroxisomal enzymes </strong>are <strong>not </strong>transported correctly into <strong>peroxisomes </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome, adrenoleukodystrophy </strong>and <strong>infantile Refsum&rsquo;s disease </strong>are together classified as <strong>Peroxisomal biogenesis disorders</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Mitochondria:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Disorders </strong>associated -<strong>Mitochondrial myopathies</strong>,<strong> Charcot-Marie-Tooth disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lysosomes:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Disorders</strong> associated &ndash;<strong> </strong><strong>Inclusion cell (I-cell) disease, sphingolipidoses</strong>, <strong>Mucopolysaccharidosis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Nucleus:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Autoimmune disorders</strong>, <strong>DNA repair defects</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Zellweger syndrome </strong>is a <strong>rare </strong>congenital disorder caused by a <strong>defect</strong> in <strong>peroxisome biogenesis, </strong>leading to various clinical symptoms such as <strong>hypotonia, hepatomegaly, developmental delays</strong>, and <strong>distinct craniofacial </strong>features.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 209, 254</span></strong></span></span></p>",
      "correct_choice_id": 36617,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9170,
      "choices": [
        {
          "id": 36647,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of very long chain fatty acid</span></span></span></p>"
        },
        {
          "id": 36648,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of medium chain fatty acid</span></span></span></p>"
        },
        {
          "id": 36649,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased plasmalogen</span></span></span></p>"
        },
        {
          "id": 36650,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased pipecolic acid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old boy is brought to a pediatric neurologist by his parents, who are concerned about recent changes in his behavior and academic performance. Over the past six months, he has exhibited signs of hyperactivity, vision problems, and hearing loss. His teachers have noted a significant decline in his attention span and comprehension skills. The neurologist, suspecting a genetic disorder affecting the metabolism of fatty acids, orders a comprehensive lipid panel including very long-chain fatty acid (VLCFA) levels:</span></span></span></p>",
      "unique_key": "Q7866694",
      "question_audio": null,
      "question_video": null,
      "map_id": 30278,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Accumulation of very long chain fatty acid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adrenoleukodystrophy (ALD) </strong>is a <strong>genetic disorder </strong>characterized by the accumulation of <strong>very long-chain fatty acids (VLCFAs) </strong>in the body due to a <strong>defect </strong>in the <strong>peroxisomal transporter protein </strong>that imports <strong>VLCFAs </strong>into <strong>peroxisomes </strong>for degradation. This <strong>accumulation </strong>is especially <strong>damaging to the myelin sheath of nerve cells</strong>, leading to <strong>progressive neurological symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Accumulation of medium chain fatty acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: ALD <strong>does not </strong>typically involve the accumulation of <strong>medium-chain fatty acids</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Increased plasmalogen</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Plasmalogens are a type of <strong>phospholipid</strong>; their levels are <strong>not directly </strong>related to <strong>ALD</strong>, which is primarily concerned with the <strong>metabolism of VLCFAs</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Decreased pipecolic acid</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pipecolic acid is associated with<strong> peroxisomal disorders </strong>like <strong>Zellweger syndrome</strong>, <strong>not </strong>specifically with <strong>ALD</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficient oxidation </strong>of <strong>VLCFA </strong>by <strong>peroxisomal enzyme systems </strong>&rarr; <strong>VLCFAs </strong>are accumulated &rarr; <strong>myelin sheaths </strong>are <strong>destroyed </strong>&rarr; <strong>adrenoleukodystrophy</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 205</span></strong></span></span></p>",
      "correct_choice_id": 36647,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9176,
      "choices": [
        {
          "id": 36671,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Citric acid cycle</span></span></span></p>"
        },
        {
          "id": 36672,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid oxidation</span></span></span></p>"
        },
        {
          "id": 36673,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
        },
        {
          "id": 36674,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pentose phosphate pathway</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following metabolic pathways generates the most ATP?</span></span></span></p>",
      "unique_key": "Q9938939",
      "question_audio": null,
      "question_video": null,
      "map_id": 30281,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid oxidation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fatty acid oxidation </strong>of <strong>palmitate </strong>results in a total of <strong>106 ATP</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A total of <strong>7 rounds of beta-oxidation </strong>yield <strong>28 ATPs</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A total of <strong>8 </strong>mol of <strong>acetyl-CoA </strong>is formed. Each gives rise to <strong>10 mol of ATP </strong>on oxidation in <strong>TCA cycle</strong>, making <strong>80 mol. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two </strong>must be subtracted for the <strong>initial activation of the fatty acid</strong>, yielding a <strong>net gain </strong>of <strong>108-2 </strong>= <strong>106 mol of ATP </strong>per mole of <strong>palmitate</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The citric acid cycle produces a net of 10 ATP per turn of the cycle</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis produces a net of 7 ATP molecules per glucose under aerobic conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pentose phosphate pathway does not generate any ATP but instead forms NADPH and ribose 5-phosphate</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid oxidation, specifically &beta;-oxidation of fatty acids, generates the most AT, because the breakdown of fatty acids yields numerous molecules of acetyl-CoA, NADH, and FADH2, all of which enter the citric acid cycle and electron transport chain to produce ATP. Fatty acids are a dense form of energy storage, and their oxidation releases a significant amount of energy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 204.</span></strong></span></span></p>",
      "correct_choice_id": 36672,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}